Article
Five percent of normal cystic fibrosis transmembrane conductance regulator mRNA ameliorates the severity of pulmonary disease in cystic fibrosis.
American journal of respiratory cell and molecular biology - 1 Nov 2002
Ramalho Anabela S, Beck Sebastian, Meyer Michelle, Penque Deborah, Cutting Garry R, Amaral Margarida D
Abstract excerpt
Estimates of the level of transcripts from the cystic fibrosis (CF) transmembrane conductance regulator (CFTR) gene required to develop a CF phenotype range from 4-20% of normal. Due to the importance of obtaining reliable data on this issue for therapeutic strategies, we developed a novel polymerase chain reaction-based method to quantify CFTR transcripts and applied it to the analysis of nasal epithelium RNA of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
